Today's Clinical Lab - News, Editorial and Products for the Clinical Laboratory
Photo of a white paper with words “antimicrobial resistance AMR” printed on it.
Traditional metagenomics has limitations in revealing microbial diversity at the strain level and profiling antibiotic resistance genes, prompting the development of this innovative method.
iStock, designer491 

Unlocking Microbial Diversity: Single-Cell Genomics Decodes Bacterial Genomes

A new study uses single-cell genomics to identify previously undetected bacterial species and enhance our understanding of antibiotic resistance within the human microbiome

Logo
Today's Clinical Lab
Logo

Today’s Clinical Lab is a reader-centric publication that keeps clinical professionals up to date with today’s rapidly changing lab industry with in-depth and timely editorial content and resources, including clinical industry news and insights into the latest trends, technologies, and techniques in the clinical lab.

ViewFull Profile
Learn about ourEditorial Policies.
Published:Oct 11, 2024
|2 min read
Register for free to listen to this article
Listen with Speechify
0:00
2:00

Researchers at Waseda University, led by associate professor Masahito Hosokawa, PhD, have pioneered a novel single-cell genome approach to explore the complexities of the human microbiome. Traditional metagenomics has limitations in revealing microbial diversity at the strain level and profiling antibiotic resistance genes, prompting the development of this innovative method. Their findings, published in Microbiome on October 2, 2024, represent a significant leap in microbial research.

“The limitation of metagenomics inspired us to develop a new approach to explore the human microbiome at the single-cell level,” Hosokawa said in a press release. “This single-cell genome approach can enhance our understanding of how bacteria interact and exchange genetic material including antibiotic resistance genes, providing deeper insights into human health and disease.”

The research involved a large-scale analysis of microbial samples from 51 participants, who provided saliva and fecal samples. Utilizing SAG-gel technology, commercialized as bit-MAP® by bitBiome, Inc., individual bacteria were encapsulated in a gel, allowing for the amplification and analysis of their genomes. This technique resulted in the recovery of genomes from 300 bacterial species that traditional methods had missed.

The study's analysis encompassed 30,000 individual genomes of oral and intestinal bacteria, creating the largest genomic dataset of its kind. The study showcases the power of single-cell genomics for elucidating microbial diversity and interactions.

The implications of this research are far-reaching. In public health, the detailed profiling of antibiotic resistance genes can lead to more effective treatment strategies and disease prevention. Additionally, the technique holds potential for environmental monitoring and agricultural practices, helping manage the spread of antibiotic resistance across ecosystems.

This groundbreaking work underscores the transformative potential of single-cell genomics in microbiome research, offering valuable insights that could enhance medical and public health applications in the future.

Note: This news summary was generated by AI based on a published press release, followed by a review from human editors.

Related Articles: